Cardiac biosensors represent a cutting-edge technology in the field of healthcare and diagnostics, offering innovative solutions for monitoring and assessing cardiovascular health. These biosensors leverage advanced sensing technologies to detect specific biomarkers or physiological signals associated with cardiac conditions. By providing real-time and accurate data, cardiac biosensors empower healthcare professionals to make timely and informed decisions, leading to more personalized and effective patient care. These devices play a pivotal role in early detection, continuous monitoring, and management of cardiovascular diseases, contributing to improved patient outcomes. As research and development in the realm of biosensing technologies continue to advance, the integration of cardiac biosensors holds great promise for enhancing the precision and efficiency of cardiovascular healthcare, paving the way for a future where proactive and personalized cardiac monitoring becomes a standard in patient care.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain